Ythdf2-deficient NK cells have impaired antiviral functions. (A) 2.5 × 104 PFU MCMV were injected i.p. into Ythdf2WT and Ythdf2ΔNK mice. Weight loss of Ythdf2WT and Ythdf2ΔNK mice at various times after infection is shown, presented as relative weights compared with before infection (n = 5 mice for MCMV groups, and n = 3 for PBS groups). (B) Viral titers in peripheral blood mononuclear cells on day 7 after infection were assessed by qPCR. Mice injected with PBS were used as control (n = 5 mice for MCMV groups; n = 3 for PBS groups). (C and D) The percentage and absolute number of NK cells in the spleen from Ythdf2WT and Ythdf2ΔNK mice on days 0, 4, 7 after infection with MCMV (n = 3 at days 0 and 4; n = 5 at day 7). (E–G) Representative plots (E) and quantification of Ki67 expression by NK cells in the spleen (F) and blood (G) from Ythdf2WT and Ythdf2ΔNK mice on day 7 after infection (n = 5 mice per group). (H–J) Representative plots (H) and quantification of the percentage (I) and absolute number (J) of Ly49H+ NK cells in spleen from Ythdf2WT and Ythdf2ΔNK mice on days 0, 4, 7 after infection with MCMV (n = 3 at days 0 and 4; n = 5 at day 7). (K–M) Representative plots (K) and quantification of perforin expression by NK cells in the spleen (L) and blood (M) from Ythdf2WT and Ythdf2ΔNK mice on day 7 after infection (n = 5 mice per group). Data are shown as mean ± SD and were analyzed by unpaired two-tailed t test (F, G, L, and M), one-way ANOVA with Šídák post-test (B), or two-way ANOVA with Šídák post-test (A, C, D, I, and J). Data are representative of at least three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.